NCT03662100View on ClinicalTrials.gov

A Study of Two Formulations of LY3074828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

January 25, 2019

Study Completion Date

January 25, 2019

Conditions
Healthy
Interventions
BIOLOGICAL

LY3074828

Administered SC

DRUG

LY3074828

Administered SC

DEVICE

Auto-injector (AI)

AI to administer LY3074828

DEVICE

Prefilled syringe (PFS)

PFS to administer LY3074828

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03662100 - A Study of Two Formulations of LY3074828 in Healthy Participants | Biotech Hunter | Biotech Hunter